Studie - Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, emerging business models and leading innovators
Business Insights
11 / 2010
171 Seiten
| Typ: | Studie |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Diabetes affects over 285 million people around the world and this it forecast to increase to 438 million by 2030. Diabetes is strongly associated with obesity; the term 'diabesity” is increasingly being used by researchers in this field. Leading diabetes associations encourage the adoption of a 'healthy” diet, low in saturated fats and carbohydrates and rich in fruit and vegetables to improve blood sugar control, reduce weight gain, and minimize long-term complications. In addition, low glycemic index (GI) diets may be useful in weight control, and help reduce insulin levels and insulin resistance Food, ingredient and drinks manufacturers have adopt a variety of strategies to improve the nutritious content of food and beverages in response to dietary guidelines and the rising diabetes epidemic. Whilst the first phase has targeted a reduction in salt, fat and sugar (often through the incorporation of artificial low calorie sweeteners); companies are now turning to additional nutrients and functional ingredients to promote health benefits. These include the incorporation of vitamins and mineral, modified fibers and prebiotics as well as a diverse range of phytonutrients.
This report reviews the business strategies of leading companies in the development of novel products that can improve blood glucose control and weight management. It discusses the changes in regulation and reviews health claims associated with functional ingredients and supplements. It highlights the important role of personalized nutrition in the treatment and prevention of diabetes.
Scope of this research
* Identifies ingredient and supplements that may be beneficial in the treatment and prevention of diabetes and reviews the evidence to support claims.
* Review market drivers regarding the uptake of 'healthier” foods in blood glucose management and the personalization of nutrition.
* Assess the impact diabetes in the emerging economies and discuss the ways in which emerging consumer may be targeted.
* Review regulations to gain insight into the effect of these regulations on the industry in the near future.
* Identify points of convergence of the pharma, food and drinks markets in the prevention of diabetes and the emergence of healthcare nutrition.
Research and analysis highlights
The food market is changing: Over the past decade, consumers have become more concerned for their health and wellbeing. The roll of the food and drinks industry is changing and shifting towards a more benefit driven and preventative approach.
Regulations in this competitive marketplace are evolving to encourage innovation whilst protect consumer safety. This is particularly pertinent given the gap between the regulation of supplements and that of functional ingredients.
Rising cost of product development: Companies are increasingly using a science driven approach to development new products which target diabetes. This cost time and resources and requires technical expertise. Through strategic alliances and acquisitions companies have begun to expand their product portfolios and technological capabilities.
Key reasons to purchase this research
* Which companies and innovative products are available to diabetic consumers and what strategies and ingredients are companies adopting?
* In what ways are companies utilising technologies to identify and validate new products which help regulate blood glucose, and to support claims?
* What new market opportunities exist for food and drinks manufacturers to strengthen the line between food and pharma in the prevention of diabetes?
* What the are key drivers for the emergence of healthcare nutrition and the development of personalized nutrition for diabetics, now and in the future?
* What is the regulatory status of ingredients and supplements which target diabetes and how will changes in these regulations affect the industry?
This report reviews the business strategies of leading companies in the development of novel products that can improve blood glucose control and weight management. It discusses the changes in regulation and reviews health claims associated with functional ingredients and supplements. It highlights the important role of personalized nutrition in the treatment and prevention of diabetes.
Scope of this research
* Identifies ingredient and supplements that may be beneficial in the treatment and prevention of diabetes and reviews the evidence to support claims.
* Review market drivers regarding the uptake of 'healthier” foods in blood glucose management and the personalization of nutrition.
* Assess the impact diabetes in the emerging economies and discuss the ways in which emerging consumer may be targeted.
* Review regulations to gain insight into the effect of these regulations on the industry in the near future.
* Identify points of convergence of the pharma, food and drinks markets in the prevention of diabetes and the emergence of healthcare nutrition.
Research and analysis highlights
The food market is changing: Over the past decade, consumers have become more concerned for their health and wellbeing. The roll of the food and drinks industry is changing and shifting towards a more benefit driven and preventative approach.
Regulations in this competitive marketplace are evolving to encourage innovation whilst protect consumer safety. This is particularly pertinent given the gap between the regulation of supplements and that of functional ingredients.
Rising cost of product development: Companies are increasingly using a science driven approach to development new products which target diabetes. This cost time and resources and requires technical expertise. Through strategic alliances and acquisitions companies have begun to expand their product portfolios and technological capabilities.
Key reasons to purchase this research
* Which companies and innovative products are available to diabetic consumers and what strategies and ingredients are companies adopting?
* In what ways are companies utilising technologies to identify and validate new products which help regulate blood glucose, and to support claims?
* What new market opportunities exist for food and drinks manufacturers to strengthen the line between food and pharma in the prevention of diabetes?
* What the are key drivers for the emergence of healthcare nutrition and the development of personalized nutrition for diabetics, now and in the future?
* What is the regulatory status of ingredients and supplements which target diabetes and how will changes in these regulations affect the industry?
Table of Contents
About the author 2
Disclaimer 2
Executive summary 11
Introduction 11
Ingredients and supplements 12
Functional foods and drinks 13
Medical foods 14
Convergence of pharma, food & drinks in diabetes 14
Challenges and opportunities in the prevention and treatment of diabetes 16
Chapter 1 Introduction 17
Summary 17
Introduction 18
Diabetes, obesity and lifestyle changes 20
Diagnosis 23
Long term complications 24
Dietary impact 24
Prevention & treatment 28
Market opportunities 31
The Food Ingredients Sector 31
Fortified/functional foods 33
Dietary supplements 34
Medical foods 35
Pharmaceutical products 35
Report outline 37
Chapter 2 Ingredients and supplements 38
Summary 38
Introduction 39
Increasing insulin secretion & insulin sensitivity 41
Botanicals & Natural Product Extracts 42
Bitter melon 42
Gymnema sylvestre 44
Heartwood 45
Product case study: Diabecon (The Himalaya Drug Company) 46
Reducing oxidative stress 48
Minerals & Vitamins 49
Minerals 49
Vitamins 49
Phytonutrients 51
Cinnamon 51
Green tea 52
Reducing glucose absorption 53
Banaba 54
Fenugreek 54
Salvia hispanica 55
Soy protein 55
Reducing inflammation 56
Omega 3 56
Reducing sugar cravings & sugar intake 57
Rebiana 58
Conclusions 59
Chapter 3 Functional food and drinks 60
Summary 60
Introduction 61
Artificial & natural sweeteners 63
Functional food & drinks 66
New product developments 69
Functional foods 72
Fiber enriched foods 72
Case Study: General Mills 74
Fiber-like resistant starch 76
Case Study: Cargill 77
Non-digestible prebiotic fiber 78
Case Study: BENEO group 79
Sugar free & low calorie confectionery 81
Case study: Mars Inc 82
Conclusions on functional foods 83
Functional drinks 83
Nutritional supplement drinks & shakes 84
Fiber enriched drinks 84
Protein enriched drinks 85
Soft drinks 86
Carbonated drinks 86
Case study: PepsiCo 87
Products 87
Research & development 87
Fortified waters 88
Case study: CocaCola 89
Fortified & functional fruit juices 90
Hot drinks 91
Case study: Unilever 93
Research 94
Conclusions on functional drinks 94
Overall conclusions 95
Chapter 4 Medical foods 96
Summary 96
Introduction 97
Diabetes-specific formulas 98
Case Study: Abbott Nutrition 100
Case Study: Ajinomoto 104
Case Study: Groupe Danone 105
Case Study: Nestlé 108
Case Study: Kalbe Nutritionals 111
Case Study: Victus Inc 112
Conclusions 113
Chapter 5 Convergence of pharma, biotech, food and drinks 115
Summary 115
Introduction 116
New targets for weight management & diabetes 117
Case Study: EGCG 119
Case Study: Hoodia extract 119
Case study: WG0401 120
Case study: InterMed Discovery 120
New targets for diabetes 121
Case study: Madeglucyl 122
Case study: Resveratrol 123
New targets for diabetic complications 124
Emerging business models 124
R&D constraints 125
Science a major driver 126
Predictive health status biomarkers 127
Application of nutrigenomics 128
Personalization of nutrition 130
Clinical assessment of new ingredients & products with health benefits 132
Case Study: Medicus Research 133
Regulatory requirements for dietary & health benefit claims 135
Conclusions 137
Chapter 6 Challenges & opportunities in the prevention & treatment of
diabetes 139
Summary 139
Introduction 140
Challenges 140
Changing regulatory environment 140
Changing dietary guidelines 142
Consumer education 144
Rising costs of product development 146
Commercial application of nutrigenomics 147
Opportunities 147
The emerging consumer 147
Evolution of healthcare nutrition 150
Targeting diabetic complications & high risk consumers 151
Identification of functional ingredients & foods 152
Market trends 153
Overall Conclusions 154
Chapter 7 Appendix 155
Primary research methodology 155
Acknowledgments 155
Glossary 156
Bibliography 158
Table of figures
Figure 1: Nutrition and Medical Nutrition Therapy (MNT) 19
Figure 2: Prevalence (%) estimates of diabetes (20-79) by region, 2010 and 2030 20
Figure 3: Impact of low and high GI foods on Blood glucose 25
Figure 4: Traffic light for GI foods 26
Figure 5: Foods most likely to be avoided by consumers in 2008 and 2010 27
Figure 6: Ingredients, supplements and nutrients 28
Figure 7: Leading oral/injectable anti diabetic drugs 29
Figure 8: The health and nutrition sector 31
Figure 9: Key US consumer health concerns, 2007 32
Figure 10: The role of food and pharmaceuticals in the healthcare continuum 33
Figure 11: Hormonal control of blood glucose 42
Figure 12: Reduction in blood sugar levels in type 2 diabetic patients using Diabecon 48
Figure 13: Cinnamon products 52
Figure 14: Green Tea products 53
Figure 15: Fenugreek products 55
Figure 16: Traffic Light Labelling 62
Figure 17: New product developments targeting diabetes, 2005-2010* 71
Figure 18: Diabetic Lifestyle low glycemic fiber enriched bread for diabetics 73
Figure 19: U.S. General Mills Uncle Sam Low GI Cereal 74
Figure 20: Racconto Essentials resistant starch enriched pasta suitable for diabetics 77
Figure 21: Snugbury prebiotic fiber enriched diabetic ice cream 79
Figure 22: Fiber enriched GlucoBurst diabetic drink 85
Figure 23: Functional soft drinks suitable for diabetics 86
Figure 24: Fortified water suitable for diabetics 88
Figure 25: Dog On It! fortified juices targeting young diabetics 91
Figure 26: Different types of medical food and their uses 99
Figure 27: Abbotts leading medical foods 102
Figure 28: Danone’s Diasip 106
Figure 29: Nestlé Nutren range 109
Figure 30: Nestlé Boost Glucose Control 110
Figure 31: Kalbe Nutritionals’ Diabetasol 112
Figure 32: Victus’ Enterex range 113
Figure 33: Therapeutic targets for regulation of food intake 118
Figure 34: R&D investment of the food and drink industry around the world 126
Figure 35: Scientific and technological expertise driving health nutrition 131
Figure 36: Nestlés research and translational model: Diabetes 132
Figure 37: Medicus Research CRO services for Natural Product Development 134
Figure 38: Challenges and opportunities in the prevention of diabetes 140
Figure 39: Global population failing to achieve recommended intake 145
Figure 40: Factors influencing purchasing decisions 146
Figure 41: Emerging consumers 148
Figure 42: Emerging consumer segmentation 149
Figure 43: New business models driving healthcare nutrition 150
Figure 44: Diabetic complications 152
Table of tables
Table 1: Definitions of terms relating to diabetes 22
Table 2: Prevention and treatment strategies for diabetes 40
Table 3: Ingredient profile 47
Table 4: Natural & Artificial Sweeteners Approved in the US 64
Table 5: Natural & Artificial Sweeteners Approved in the US (continued) 65
Table 6: Superfruits 68
Table 7: Superfruits (continued) 69
Table 8: Functional herbal teas 92
Table 9: Medical foods and companies 101
Table 10: Drivers of pharma and food and drink products 125
Table 11: Strategic alliances and investments in R&D technologies 127
Table 12: Food choices for diabetes recommended by Nutrition Subcommittee of the Diabetes
Care Advisory Committee of Diabetes UK 143
About the author 2
Disclaimer 2
Executive summary 11
Introduction 11
Ingredients and supplements 12
Functional foods and drinks 13
Medical foods 14
Convergence of pharma, food & drinks in diabetes 14
Challenges and opportunities in the prevention and treatment of diabetes 16
Chapter 1 Introduction 17
Summary 17
Introduction 18
Diabetes, obesity and lifestyle changes 20
Diagnosis 23
Long term complications 24
Dietary impact 24
Prevention & treatment 28
Market opportunities 31
The Food Ingredients Sector 31
Fortified/functional foods 33
Dietary supplements 34
Medical foods 35
Pharmaceutical products 35
Report outline 37
Chapter 2 Ingredients and supplements 38
Summary 38
Introduction 39
Increasing insulin secretion & insulin sensitivity 41
Botanicals & Natural Product Extracts 42
Bitter melon 42
Gymnema sylvestre 44
Heartwood 45
Product case study: Diabecon (The Himalaya Drug Company) 46
Reducing oxidative stress 48
Minerals & Vitamins 49
Minerals 49
Vitamins 49
Phytonutrients 51
Cinnamon 51
Green tea 52
Reducing glucose absorption 53
Banaba 54
Fenugreek 54
Salvia hispanica 55
Soy protein 55
Reducing inflammation 56
Omega 3 56
Reducing sugar cravings & sugar intake 57
Rebiana 58
Conclusions 59
Chapter 3 Functional food and drinks 60
Summary 60
Introduction 61
Artificial & natural sweeteners 63
Functional food & drinks 66
New product developments 69
Functional foods 72
Fiber enriched foods 72
Case Study: General Mills 74
Fiber-like resistant starch 76
Case Study: Cargill 77
Non-digestible prebiotic fiber 78
Case Study: BENEO group 79
Sugar free & low calorie confectionery 81
Case study: Mars Inc 82
Conclusions on functional foods 83
Functional drinks 83
Nutritional supplement drinks & shakes 84
Fiber enriched drinks 84
Protein enriched drinks 85
Soft drinks 86
Carbonated drinks 86
Case study: PepsiCo 87
Products 87
Research & development 87
Fortified waters 88
Case study: CocaCola 89
Fortified & functional fruit juices 90
Hot drinks 91
Case study: Unilever 93
Research 94
Conclusions on functional drinks 94
Overall conclusions 95
Chapter 4 Medical foods 96
Summary 96
Introduction 97
Diabetes-specific formulas 98
Case Study: Abbott Nutrition 100
Case Study: Ajinomoto 104
Case Study: Groupe Danone 105
Case Study: Nestlé 108
Case Study: Kalbe Nutritionals 111
Case Study: Victus Inc 112
Conclusions 113
Chapter 5 Convergence of pharma, biotech, food and drinks 115
Summary 115
Introduction 116
New targets for weight management & diabetes 117
Case Study: EGCG 119
Case Study: Hoodia extract 119
Case study: WG0401 120
Case study: InterMed Discovery 120
New targets for diabetes 121
Case study: Madeglucyl 122
Case study: Resveratrol 123
New targets for diabetic complications 124
Emerging business models 124
R&D constraints 125
Science a major driver 126
Predictive health status biomarkers 127
Application of nutrigenomics 128
Personalization of nutrition 130
Clinical assessment of new ingredients & products with health benefits 132
Case Study: Medicus Research 133
Regulatory requirements for dietary & health benefit claims 135
Conclusions 137
Chapter 6 Challenges & opportunities in the prevention & treatment of
diabetes 139
Summary 139
Introduction 140
Challenges 140
Changing regulatory environment 140
Changing dietary guidelines 142
Consumer education 144
Rising costs of product development 146
Commercial application of nutrigenomics 147
Opportunities 147
The emerging consumer 147
Evolution of healthcare nutrition 150
Targeting diabetic complications & high risk consumers 151
Identification of functional ingredients & foods 152
Market trends 153
Overall Conclusions 154
Chapter 7 Appendix 155
Primary research methodology 155
Acknowledgments 155
Glossary 156
Bibliography 158
Table of figures
Figure 1: Nutrition and Medical Nutrition Therapy (MNT) 19
Figure 2: Prevalence (%) estimates of diabetes (20-79) by region, 2010 and 2030 20
Figure 3: Impact of low and high GI foods on Blood glucose 25
Figure 4: Traffic light for GI foods 26
Figure 5: Foods most likely to be avoided by consumers in 2008 and 2010 27
Figure 6: Ingredients, supplements and nutrients 28
Figure 7: Leading oral/injectable anti diabetic drugs 29
Figure 8: The health and nutrition sector 31
Figure 9: Key US consumer health concerns, 2007 32
Figure 10: The role of food and pharmaceuticals in the healthcare continuum 33
Figure 11: Hormonal control of blood glucose 42
Figure 12: Reduction in blood sugar levels in type 2 diabetic patients using Diabecon 48
Figure 13: Cinnamon products 52
Figure 14: Green Tea products 53
Figure 15: Fenugreek products 55
Figure 16: Traffic Light Labelling 62
Figure 17: New product developments targeting diabetes, 2005-2010* 71
Figure 18: Diabetic Lifestyle low glycemic fiber enriched bread for diabetics 73
Figure 19: U.S. General Mills Uncle Sam Low GI Cereal 74
Figure 20: Racconto Essentials resistant starch enriched pasta suitable for diabetics 77
Figure 21: Snugbury prebiotic fiber enriched diabetic ice cream 79
Figure 22: Fiber enriched GlucoBurst diabetic drink 85
Figure 23: Functional soft drinks suitable for diabetics 86
Figure 24: Fortified water suitable for diabetics 88
Figure 25: Dog On It! fortified juices targeting young diabetics 91
Figure 26: Different types of medical food and their uses 99
Figure 27: Abbotts leading medical foods 102
Figure 28: Danone’s Diasip 106
Figure 29: Nestlé Nutren range 109
Figure 30: Nestlé Boost Glucose Control 110
Figure 31: Kalbe Nutritionals’ Diabetasol 112
Figure 32: Victus’ Enterex range 113
Figure 33: Therapeutic targets for regulation of food intake 118
Figure 34: R&D investment of the food and drink industry around the world 126
Figure 35: Scientific and technological expertise driving health nutrition 131
Figure 36: Nestlés research and translational model: Diabetes 132
Figure 37: Medicus Research CRO services for Natural Product Development 134
Figure 38: Challenges and opportunities in the prevention of diabetes 140
Figure 39: Global population failing to achieve recommended intake 145
Figure 40: Factors influencing purchasing decisions 146
Figure 41: Emerging consumers 148
Figure 42: Emerging consumer segmentation 149
Figure 43: New business models driving healthcare nutrition 150
Figure 44: Diabetic complications 152
Table of tables
Table 1: Definitions of terms relating to diabetes 22
Table 2: Prevention and treatment strategies for diabetes 40
Table 3: Ingredient profile 47
Table 4: Natural & Artificial Sweeteners Approved in the US 64
Table 5: Natural & Artificial Sweeteners Approved in the US (continued) 65
Table 6: Superfruits 68
Table 7: Superfruits (continued) 69
Table 8: Functional herbal teas 92
Table 9: Medical foods and companies 101
Table 10: Drivers of pharma and food and drink products 125
Table 11: Strategic alliances and investments in R&D technologies 127
Table 12: Food choices for diabetes recommended by Nutrition Subcommittee of the Diabetes
Care Advisory Committee of Diabetes UK 143
- The Packaging of Retail Non-Alcoholic Drinks in Argentina, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Australia, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Austria, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Belgium, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Brazil, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Bulgaria, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Canada, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Chile, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in China, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Colombia, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Finland, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in France, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Germany, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Greece, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in India, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Indonesia, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Israel, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Italy, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Japan, 2007 to 2017
- The Packaging of Retail Non-Alcoholic Drinks in Malaysia, 2007 to 2017
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:
Seite drucken
Seite empfehlen
Home | Werbung | Über marktforschung.de | AGB | Impressum | Sitemap | Suche © 2006 bis 2013 Alle Rechte bei marktforschung.de - Studie - Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, emerging business models and leading innovators - Marktdaten / Marktanalysen bei marktforschung.de
